WANY
EBS icon

Wealthspire Advisors (New York)’s Emergent Biosolutions EBS Stock Holding History

Wealthspire Advisors (New York)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-197
Closed -$1.74K – 1540
2025
Q3 		$1.74K Buy
+197
New +$1.53K ﹤0.01% 2640

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealthspire Advisors (New York)'s EBS Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 197 shares — an estimated $1.74K sold.

Wealthspire Advisors (New York) first reported a position in EBS in Q3 2025 and held it in 1 quarter. The position peaked at $1.74K in Q3 2025. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 197 Emergent Biosolutions shares in Q4 2025, an estimated $1.74K.
  • Wealthspire Advisors (New York) first reported a position in Emergent Biosolutions in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Emergent Biosolutions position peaked at $1.74K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.